The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Alternative Pathway of Complement in Children with Diarrhea-Associated Hemolytic Uremic Syndrome
Open accessAbstract
BACKGROUND AND OBJECTIVES: Diarrhea-associated hemolytic uremic syndrome (D+HUS) is a common cause of acute kidney injury in children. Mutations in alternative pathway (AP) complement regulatory proteins have been identified in severe cases of thrombotic microangiopathy, but the role of the AP in D+HUS has not been studied. Therefore, we determined whether plasma levels of markers of activation of the AP are increased in D+HUS and are biomarkers of the severity of renal injury that predict the need for dialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Patients were randomly selected from among participants in the HUS-SYNSORB Pk trial. Plasma samples were collected on days 1, 4, 7, and 10 after enrollment and day 28 after discharge from the hospital. Levels of two complement pathway products, Bb and SC5b-9, were determined by ELISA. RESULTS: Seventeen children (6 boys and 11 girls; age, 5.4 +/- 3.5 yr) were studied. Eight (47%) required dialysis support, and two had serious extrarenal events. On the day of enrollment, plasma levels of Bb and SC5b-9 were significantly increased in all patients compared with healthy controls (P < 0.01). The elevated concentrations normalized by day 28 after discharge. Circulating levels of complement pathway fragments did not correlate with severity of renal injury or occurrence of complications. CONCLUSIONS: Patients with acute-onset D+HUS manifest activation of the AP of complement that is temporally related to the onset of disease and that resolves within 1 mo. Therapies to inhibit the AP of complement may be useful in attenuating the severity of renal injury and extrarenal complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury
Investigators of the HUS-SYNSORB Pk Multicenter Clinical Trial, Trachtman, H., Christen, E., Cnaan, A., Patrick, J., Mai, V., Mishra, J., Jain, A., Bullington, N., & Devarajan, P. (2006) · Pediatric Nephrology · doi:10.1007/s00467-006-0146-y · Cited by 204
Self-citation
Cited by
Atypical Hemolytic–Uremic Syndrome
Noris, M., & Remuzzi, G. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0902814 · Cited by 1,338
The immune system and kidney disease: basic concepts and clinical implications
Kurts, C., Panzer, U., Anders, H.-J., & Rees, A. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3523 · Cited by 696
Shiga Toxin (Stx) Classification, Structure, and Function
Melton-Celsa, A. R. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.ehec-0024-2013 · Cited by 525
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
Noris, M., Mescia, F., & Remuzzi, G. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.195 · Cited by 383
Jodele, S., Laskin, B. L., Dandoy, C. E., Myers, K. C., El-Bietar, J., Davies, S. M., Goebel, J., & Dixon, B. P. (2015) · Blood Reviews · doi:10.1016/j.blre.2014.11.001 · Cited by 353
Metadata
- Authors
- Thurman, J. M., Marians, R., Emlen, W., Wood, S., Smith, C., Akana, H., Holers, V. M., Lesser, M., Kline, M., Hoffman, C., Christen, E., & Trachtman, H.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2009-12
- Volume
- 4
- Issue
- 12
- Pages
- 1920-1924
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2169673413
- Cited by
- 203
- References
- 1
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Alternative Pathway of Complement in Children with Diarrhea-Associated Hemolytic Uremic Syndrome. https://app.cochat.ai/papers/10.2215/cjn.02730409
- The paper
- Thurman, J. M., Marians, R., Emlen, W., Wood, S., Smith, C., Akana, H., Holers, V. M., Lesser, M., Kline, M., Hoffman, C., Christen, E., & Trachtman, H. (2009). Alternative Pathway of Complement in Children with Diarrhea-Associated Hemolytic Uremic Syndrome. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.02730409
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.